Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

OBJECTIVES. This randomized clinical trial tested whether fish oil supplements can improve human coronary atherosclerosis. BACKGROUND. Epidemiologic studies of populations whose intake of oily fish is high, as well as laboratory studies of the effects of the polyunsaturated fatty acids in fish oil, support the hypothesis that fish oil is antiatherogenic. METHODS. Patients with angiographically documented coronary heart disease and normal plasma lipid levels were randomized to receive either fish oil capsules (n = 31), containing 6 g of n-3 fatty acids, or olive oil capsules (n = 28) for an average duration of 28 months. Coronary atherosclerosis on angiography was quantified by computer-assisted image analysis. RESULTS. Mean (+/- SD) baseline characteristics were age 62 +/- 7 years, plasma total cholesterol concentration 187 +/- 31 mg/dl (4.83 +/- 0.80 mmol/liter) and triglyceride levels 132 +/- 70 mg/dl (1.51 +/- 0.80 mmol/liter). Fish oil lowered triglyceride levels by 30% (p = 0.007) but had no significant effects on other plasma lipoprotein levels. At the end of the trial, eicosapentaenoic acid in adipose tissue samples was 0.91% in the fish oil group compared with 0.20% in the control group (p < 0.0001). At baseline, the minimal lumen diameter of coronary artery lesions (n = 305) was 1.64 +/- 0.76 mm, and percent narrowing was 48 +/- 14%. Mean minimal diameter of atherosclerotic coronary arteries decreased by 0.104 and 0.138 mm in the fish oil and control groups, respectively (p = 0.6 between groups), and percent stenosis increased by 2.4% and 2.6%, respectively (p = 0.8). Confidence intervals exclude improvement by fish oil treatment of > 0.17 mm, or > 2.6%. CONCLUSIONS. Fish oil treatment for 2 years does not promote major favorable changes in the diameter of atherosclerotic coronary arteries.

This article has been cited by other articles:

				N. Guillot, E. Caillet, M. Laville, C. Calzada, M. Lagarde, and E. Vericel Increasing intakes of the long-chain {omega}-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men FASEB J, September 1, 2009; 23(9): 2909 - 2916. [Abstract] [Full Text] [PDF]

				K. He, K. Liu, M. L Daviglus, E. Mayer-Davis, N. S. Jenny, R. Jiang, P. Ouyang, L. M Steffen, D. Siscovick, C. Wu, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1111 - 1118. [Abstract] [Full Text] [PDF]

				W. Harris Omega-3 Fatty Acids: The "Japanese" Factor? J. Am. Coll. Cardiol., August 5, 2008; 52(6): 425 - 427. [Full Text] [PDF]

				D. Mozaffarian Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1991S - 1996S. [Abstract] [Full Text] [PDF]

				S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF]

				A. T. Erkkila, N. R. Matthan, D. M. Herrington, and A. H. Lichtenstein Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD J. Lipid Res., December 1, 2006; 47(12): 2814 - 2819. [Abstract] [Full Text] [PDF]

				D. Mozaffarian and E. B. Rimm Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA, October 18, 2006; 296(15): 1885 - 1899. [Abstract] [Full Text] [PDF]

				N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, K. Aonuma, I. Yamaguchi, and T. Miyauchi Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta1 and phosphorylated JNK Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H835 - H845. [Abstract] [Full Text] [PDF]

				C. Wang, W. S Harris, M. Chung, A. H Lichtenstein, E. M Balk, B. Kupelnick, H. S Jordan, and J. Lau n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clinical Nutrition, July 1, 2006; 84(1): 5 - 17. [Abstract] [Full Text] [PDF]

				J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]

				A. T Erkkila, A. H Lichtenstein, D. Mozaffarian, and D. M Herrington Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease Am. J. Clinical Nutrition, September 1, 2004; 80(3): 626 - 632. [Abstract] [Full Text] [PDF]

				H. Chen, D. Li, G. J Roberts, T. Saldeen, and J. L Mehta Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes Cardiovasc Res, July 1, 2003; 59(1): 7 - 13. [Abstract] [Full Text] [PDF]

				P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF]

				References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]

				P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF]

				P. Angerer, W. Kothny, S. Stork, and C. von Schacky Effect of dietary supplementation with {omega}-3 fatty acids on progression of atherosclerosis in carotid arteries Cardiovasc Res, April 1, 2002; 54(1): 183 - 190. [Abstract] [Full Text] [PDF]

				C. von Schacky Dietary omega-3 fatty acids and human growth factor and cytokine gene expression Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D50 - D52. [Abstract] [PDF]

				R. Marchioli Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-prevenzione trial Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D85 - D97. [Abstract] [PDF]

				R. A. Vogel, M. C. Corretti, and G. D. Plotnick The postprandial effect of components of the mediterranean diet on endothelial function J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1455 - 1460. [Abstract] [Full Text] [PDF]

				C. von Schacky n-3 Fatty acids and the prevention of coronary atherosclerosis1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 224S - 227S. [Abstract] [Full Text] [PDF]

				H. C. Bucher, L. E. Griffith, and G. H. Guyatt Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 187 - 195. [Abstract] [Full Text] [PDF]

				N. J. Stone Fish Consumption, Fish Oil, Lipids, and Coronary Heart Disease Circulation, November 1, 1996; 94(9): 2337 - 2340. [Full Text]

				Fish Flops Again Journal Watch Cardiology, July 1, 1995; 1995(701): 12 - 12. [Full Text]